Amanote Research
Register
Sign In
453. Systemic Delivery of a Peptide-Linked Morpholino Oligonucleotide Neutralizes Mutant RNA Toxicity in a Mouse Model of Myotonic Dystrophy
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34788-8
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
HNRNPA1-induced Spliceopathy in a Transgenic Mouse Model of Myotonic Dystrophy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Reversal of RNA Missplicing and Myotonia After Muscleblind Overexpression in a Mouse Poly(CUG) Model for Myotonic Dystrophy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Functional and Histopathological Identification of the Respiratory Failure in a DMSXL Transgenic Mouse Model of Myotonic Dystrophy
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Rapid Screening of Gene Function by Systemic Delivery of Morpholino Oligonucleotides to Live Mouse Embryos
PLoS ONE
Multidisciplinary
A Case of Paternally Inherited Congenital Myotonic Dystrophy.
Journal of Medical Genetics
Genetics
A -Hairpin Structure in a 13-Mer Peptide That Binds -Bungarotoxin With High Affinity and Neutralizes Its Toxicity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Peptide-Morpholino Oligomer Conjugate Targeting Staphylococcus Aureus gyrA mRNA Improves Healing in an Infected Mouse Cutaneous Wound Model
International Journal of Pharmaceutics
Pharmaceutical Science
Hearing Loss of Myotonic Dystrophy.
AUDIOLOGY JAPAN
A Resected Case of Thymus Tumor With Myotonic Dystrophy
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
